• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

India

Boston Scientific opens new R&D center in India

March 18, 2022 By Chris Newmarker

Boston Scientific (NYSE:BSX) has opened its second R&D center in India, located in the western city of Pune. According to media reports, the new center is 45,000 ft² and will initially employ 170 people, more than doubling the number of R&D employees that Boston Scientific has in India. The company’s first Indian R&D center opened […]

Filed Under: Business/Financial News, Research & Development Tagged With: Boston Scientific, India

Medtronic kicks off newly expanded R&D center in India

April 7, 2021 By Chris Newmarker

Medtronic (NYSE:MDT) today announced the inauguration of its newly expanded 150,000 ft2 Medtronic Engineering and Innovation Center (MEIC) in Hyderabad, India. The Fridley, Minn.–based medical device giant is spending $160 million over five years to turn Hyderabad into its largest R&D center outside the U.S. Medtronic expects the number of employees at the facility to […]

Filed Under: Business/Financial News, Featured, Research & Development Tagged With: India, Medtronic

Stents, knee implants undergird Trump’s new trade war with India

March 5, 2019 By Brad Perriello

The Trump administration yesterday opened hostilities in a pair of new trade wars, using India’s price caps on coronary stents and knee implants as the centerpiece of the new policy there. The White House said it plans to end India’s preferential trade status in 60 days under the Generalized System of Preference. “India’s termination from […]

Filed Under: Business/Financial News, Featured, Orthopedics, Stents, Wall Street Beat Tagged With: India, tariffs

Report: Trump admin directs USTR to monitor foreign country device, pharma price caps

May 14, 2018 By Fink Densford

The President last week ordered the US Trade Representative to take under consideration countries which are implementing price controls on American pharmaceuticals and medical devices, according to a Financial Express report. President Trump referred to such prices controls as unjustified and at the expense of America’s R&D, and implied that the US could no longer […]

Filed Under: Business/Financial News Tagged With: Capitol Hill, India

India proposes caps on use of imported med devices, priority for local makers

March 19, 2018 By Fink Densford

India’s government is proposing new regulations that could set significant caps on medical devices imported into the country, according to a new set of draft guidelines from the country’s Department of Pharmaceuticals. The new regulation would require that 50% of all medical disposables and consumables and 40% of all implants be produced locally, according to […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: India, Indian National Pharmaceutical Pricing Authority (NPPA)

India’s medical device industry protests NPPA stent price caps

February 7, 2018 By Fink Densford

Indian medical device manufacturers and associations are voicing their opposition to price caps on stents and other devices imposed by India’s National Pharmaceutical Pricing Authority, according to a report from the Economic Times India. The price cap has reportedly left little to no room for innovation in the country, with industry groups now demanding an […]

Filed Under: Business/Financial News, Stents Tagged With: AdvaMed, India, Indian National Pharmaceutical Pricing Authority (NPPA)

Report: US pressuring India to halt price caps, allow market withdrawals

October 5, 2017 By Fink Densford

The US government is pressuring India to halt the extension of price caps on medical devices and to allow businesses to withdraw their products from the market if they don’t want to sell at those rates, according to a report from The Hindu. The push came from a senior US Trade Representative, according to the […]

Filed Under: Business/Financial News, Orthopedics, Regulatory/Compliance, Stents Tagged With: India, Indian National Pharmaceutical Pricing Authority (NPPA)

India institutes price caps for orthopedic knee implants

August 16, 2017 By Fink Densford

Updated to include comment from the Association of Indian Medical Device Industry. Indian regulators are capping prices of orthopedic knee implants as the country looks to lower the cost of medical devices. The country’s drug pricing authority said today that orthopedic implants in the country had unjustified, unreasonable and irrationally high trade margins, which led […]

Filed Under: Business/Financial News, Healthcare Reform, Orthopedics, Regulatory/Compliance Tagged With: Abbott, India, Medtronic

Medtronic, Abbott could still seek exit from India’s high-end stent market

April 28, 2017 By Brad Perriello

Updated to include extra information on company plans for the market. Medtronic (NYSE:MDT) and Abbott (NYSE:ABT) could take another run at taking their high-end stents off the Indian market, after the Indian National Pharmaceutical Pricing Authority this week rejected their applications to withdraw. Abbott, Boston Scientific and Johnson & Johnson (NYSE:JNJ) have said they plan to tell Indian officials […]

Filed Under: Stents, Wall Street Beat Tagged With: India, Indian National Pharmaceutical Pricing Authority (NPPA)

Abbott denies reports it will bail on India’s high-end stent market

February 22, 2017 By Brad Perriello

Abbott (NYSE:ABT) yesterday denied reports that it’s pulling its high-end coronary stents from India’s market, after the government there put price caps in place for a variety of medical devices and drugs, including stents. India’s National Pharmaceutical Pricing Authority last week issued an order capping the price of stents at about $108 (Rs 7,260) for bare-metal devices […]

Filed Under: Cardiovascular, Stents Tagged With: Abbott, AdvaMed, Boston Scientific, India, Medtronic

India’s proposed stent pricing cap said to squash new product introductions

July 22, 2016 By Brad Perriello

India’s move toward capping the price on coronary stents reportedly has medical device makers rethinking their strategies there and even shelving new product rollouts. “With price controls, margins of all players including manufacturers will be impacted. Global stent makers may scale back introducing their top-of-the-line brands and launch value products instead,” Rana Mehta, healthcare leader at PwC […]

Filed Under: Cardiovascular, Stents Tagged With: Abbott, India, Medtronic

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS